Clinical Outcome Assessment for AT & BCI
Clinical Outcome Assessment for AT & BCI
Recruiting · NCT07407725 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Outcome Assessment for AT & BCI | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, injury, metabolic disease, motor neuron disorder, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder, spinal cord injury | Recruiting | Not applicable | 2026-05-05 | NCT07407725 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Neuralink Corp | 7 |
| Shirley Ryan AbilityLab | 76 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shirley Ryan Abilitylab | Chicago | United States | 59 |